IMC Statement on New Federal Government Task Force
Ottawa, March 18, 2026 – Canada must strengthen its approach to pharmaceutical innovation in a rapidly evolving global environment. Today’s […]
Newsroom
Stay informed on the latest developments in life sciences research, healthcare policy, and innovative medicines.
For media inquiries, please contact us at media@imc-mnc.ca.
PRESS RELEASES
Sorry, no posts were found. Please check again later.
Statements
IMC congratulates the Government of Québec on launching the new Québec Life Sciences Strategy
Ottawa, December 4, 2025 — Innovative Medicines Canada (IMC) congratulates the Government of Québec on the launch of the new […]
Federal Budget Statement
November 4, 2025 (Ottawa)—Today’s federal budget outlined ambitious plans to reduce government spending while making generational investments to strengthen Canada’s […]
IN THE NEWS
Opinion: It’s faster to fly a human around the moon than to get a new drug to Canadians
By Dr. Bettina Hamelin Article originally published on Healthing.ca, July 21, 2026. This spring, Canada made history when astronaut Jeremy Hansen […]
A Critical Moment for Canada: Ensuring World-Leading Access to Innovative Medicines
In this episode of From the Burgundy Chairs, Santis Health Senior Advisor Avis Favaro sits down with Dr. Bettina Hamelin, […]
The task force that could get things right for Canadian patients
Article by Bettina Hamelin originally published in the Hill Times Health Policy Briefing, page 21, April 22, 2026. By Dr. […]
Contact
Have a question or need assistance? We’re here to help.
Sponsorship applications
Innovative Medicines Canada supports initiatives that advance research, raise awareness, and improve access to innovative medicines.
Patient Stories
JOIN MEDIA LIST
Be the first to get our news
Sign up to our newsletter to get our latest news and updates.
Areas of work
Better health outcomes start with better policy. Explore the issues where IMC is pushing for change on behalf of patients, healthcare professionals and Canada’s life sciences sector.
Access to medicine
Timely access to new medicines saves lives, improves health outcomes…
Pharmacare
One size does not fit all 97% of Canadians are already eligible for drug coverage. Moving to a one-size-fits-all system […]
Patented Medicine Prices Review Board (PMPRB)
The Patented Medicine Prices Review Board (PMPRB) is responsible for ensuring that patented medicines sold in Canada are not excessively […]
Drugs for rare diseases (DRD)
One in 12 Canadians, two-thirds of them children, lives with a rare disease. IMC advocates for policies that improve and […]
Private drug coverage
The value of private drug coverage in Canada More than 27 million Canadians – nearly 70% of the population – […]
